1. Department of Health and Human Services (US), Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Guidance for Industry: premarketing Risk Assessment; March 2005.
2. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Guideline for Good Clinical Practice E6(R1); June 1996.
3. Department of Health and Human Services (US), Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Guidance for Industry: E6 Good Clinical Practice: consolidated Guidance; April 1996.
4. Council for International Organizations of Medical Sciences. Management of Safety Information from Clinical Trials: report of CIOMS Working Group VI; CIOMS; April 2005.
5. Department of Health and Human Services (US), Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment; March 2005.